Franklin India Technology Fund-Growth vs Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

Side-by-side comparison of NAV, returns, expense ratio and star rating.

TopFund Analysis

Franklin India Technology Fund-Growth appears stronger in terms of star rating with a 5-star rating compared to Nippon India Pharma Fund's 2-star rating, indicating a better performance track record. However, while Franklin India has a lower AUM of ₹1742 Cr, Nippon India boasts a significantly higher AUM of ₹9166 Cr, which might suggest greater investor confidence. Additionally, Franklin India has a higher expense ratio of 1.16% compared to Nippon India's 0.99%, which could impact net returns. For investors choosing between them, the Franklin India Technology Fund may offer better quality but comes with higher costs and lower recent returns.

Franklin Templeton Mutual Fund

Franklin India Technology Fund-Growth

Franklin Templeton Mutual Fund

★★★★★

Equity · Sectoral

Nippon India Mutual Fund

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

Nippon India Mutual Fund

★★★★★

Equity · Sectoral

Metric Franklin India Technol... Nippon India Pharma Fu...
NAV ₹544.36 ₹646.81
Star Rating ★★★★★ ★★
Expense Ratio 1.16% 0.99%
AUM ₹1,742 Cr ₹9,166 Cr
1M Return +5.45% +3.04%
3M Return -0.29% +0.74%
6M Return +13.03% +7.9%
1Y Return -5.8% +10.92%
3Y CAGR +10.29% +18.96%
5Y CAGR +7.22% +14.59%
Risk Level — —
Fund Manager Anand Radhakrishnan, Srikesh Nair, Varun Sharma Sailesh Raj Bhan